Want to join the conversation?
David Risinger of Morgan Stanley asks about Enbrel, ex-US, what percentage of revenue is in countries where biosimilars are launching in 2016. $PFE said that on the Enbrel business, the company does not have an exact figure on hand, but said more than 50% of the ex-US business would be in the European Union.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!